Cargando…

Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment

SIMPLE SUMMARY: Immune system counteracts tumor growth through a coordinated action of several innate and adaptative cells able to detect and eliminate altered cells. Among immune cells able to kill tumor cells, Natural killer (NK) cells belong to the innate arm of the immune system and distinguish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paolini, Rossella, Molfetta, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527063/ https://www.ncbi.nlm.nih.gov/pubmed/37760586 http://dx.doi.org/10.3390/cancers15184616

Ejemplares similares

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
por: Fionda, Cinzia, et al.
Publicado: (2015)

Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention
por: Molfetta, Rosa, et al.
Publicado: (2019)

Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
por: Molfetta, Rosa, et al.
Publicado: (2017)

SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses
por: Molfetta, Rosa, et al.
Publicado: (2023)

Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor
por: Di Pace, Anna Laura, et al.
Publicado: (2020)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
por: Tong, Le, et al.
Publicado: (2023)

DNAM-1 controls NK cell activation via an ITT-like motif
por: Zhang, Zhanguang, et al.
Publicado: (2015)

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
por: Mantovani, Stefania, et al.
Publicado: (2022)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
por: Zingoni, Alessandra, et al.
Publicado: (2013)

The Controversial Role of Intestinal Mast Cells in Colon Cancer
por: Molfetta, Rosa, et al.
Publicado: (2023)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
por: Fionda, Cinzia, et al.
Publicado: (2015)

CD155 and Its Receptors as Targets for Cancer Therapy
por: Paolini, Rossella, et al.
Publicado: (2023)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
por: Fionda, Cinzia, et al.
Publicado: (2022)

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
por: Capuano, Cristina, et al.
Publicado: (2017)

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
por: Walwyn-Brown, Katherine, et al.
Publicado: (2018)

Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells
por: Zitti, Beatrice, et al.
Publicado: (2017)

Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
por: Lenac Rovis, Tihana, et al.
Publicado: (2016)

Dynamic of Circulating DNAM-1+ Monocytes and NK Cells in Patients with STEMI Following Primary Percutaneous Coronary Intervention
por: Kumric, Marko, et al.
Publicado: (2022)

Accelerated tumor growth in mice deficient in DNAM-1 receptor
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2008)

Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation
por: Fionda, Cinzia, et al.
Publicado: (2021)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
por: Li, Qing, et al.
Publicado: (2022)

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
por: Cifaldi, Loredana, et al.
Publicado: (2019)

Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia
por: Valhondo, Isabel, et al.
Publicado: (2020)

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer
por: Maas, Ralph Ja, et al.
Publicado: (2020)

Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020)

Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
por: Niu, Chao, et al.
Publicado: (2016)

FcεRI Signaling in the Modulation of Allergic Response: Role of Mast Cell-Derived Exosomes
por: Lecce, Mario, et al.
Publicado: (2020)

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
por: Gilfillan, Susan, et al.
Publicado: (2008)

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation
por: Kraus, Anna K., et al.
Publicado: (2016)

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

NK cell exhaustion in the tumor microenvironment
por: Jia, Hao, et al.
Publicado: (2023)

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
por: Veneziani, Irene, et al.
Publicado: (2019)

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
por: Fionda, Cinzia, et al.
Publicado: (2015)

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
por: Sayitoglu, Ece Canan, et al.
Publicado: (2020)

The Adverse Impact of Tumor Microenvironment on NK-Cell
por: Hu, Ziming, et al.
Publicado: (2021)

DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions
por: Reymond, Nicolas, et al.
Publicado: (2004)

DNAM-1: would the real natural killer cell please stand up!
por: Huntington, Nicholas D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_25nspoadpsjs735c3bcgk800qd